Schedule 13G ownership disclosure

LIXTE BIOTECHNOLOGY HLDGS IN

Common Stock, par value $0.0001 per share · CUSIP: 539319301

Event date: 2025-02-11

Filing-level shares
217,392.00
Percent of class
8.1%
  • Orca Capital AG

    Shares: 217,392.00 · Class: 8.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-006465
Form type
SCHEDULE 13G
Filer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK
CIK 1335105
Filed
Feb 13, 2025
Reporting period
Feb 11, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub